CCND2 and plasma cell myeloma: For example, in multiple myeloma cells, APRIL promotes cell cycle progression in cyclin D2-positive cells by upregulating CDK4, CDK6, and phospho-retinoblastoma protein, but did not regulated cell-cycle proteins in cyclin D1-positive cells [23].